GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » Cyclically Adjusted Revenue per Share

Bcworldpharm Co (XKRX:200780) Cyclically Adjusted Revenue per Share : ₩7,543.76 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bcworldpharm Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩1,935.986. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩7,543.76 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-04), Bcworldpharm Co's current stock price is ₩5750.00. Bcworldpharm Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩7,543.76. Bcworldpharm Co's Cyclically Adjusted PS Ratio of today is 0.76.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Bcworldpharm Co was 0.91. The lowest was 0.77. And the median was 0.86.


Bcworldpharm Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bcworldpharm Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co Cyclically Adjusted Revenue per Share Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 7,504.20

Bcworldpharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 7,504.20 7,543.76

Competitive Comparison of Bcworldpharm Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Cyclically Adjusted PS Ratio falls into.



Bcworldpharm Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bcworldpharm Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1935.986/118.8477*118.8477
=1,935.986

Current CPI (Mar. 2024) = 118.8477.

Bcworldpharm Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1,622.128 99.353 1,940.416
201409 1,780.547 99.608 2,124.467
201412 1,477.726 99.098 1,772.229
201503 1,456.685 99.720 1,736.098
201506 1,221.093 100.050 1,450.516
201509 1,271.947 100.110 1,510.019
201512 1,255.511 100.220 1,488.870
201603 1,223.055 100.560 1,445.478
201606 1,251.302 100.790 1,475.487
201609 1,218.344 101.460 1,427.138
201612 1,439.085 101.560 1,684.048
201703 1,424.784 102.850 1,646.401
201706 1,309.921 102.610 1,517.212
201709 1,398.969 103.490 1,606.573
201712 2,213.206 102.990 2,553.980
201803 1,515.790 104.100 1,730.530
201806 1,774.185 104.130 2,024.948
201809 1,724.500 105.650 1,939.923
201812 1,541.415 104.350 1,755.569
201903 1,412.346 104.490 1,606.413
201906 1,368.437 104.880 1,550.683
201909 1,429.589 105.200 1,615.051
201912 2,146.239 105.120 2,426.518
202003 1,789.376 105.540 2,015.001
202006 1,721.656 104.870 1,951.129
202009 1,624.723 106.200 1,818.216
202012 1,621.879 105.765 1,822.492
202103 1,707.767 107.357 1,890.550
202106 1,806.948 107.579 1,996.230
202109 1,816.943 108.759 1,985.483
202112 1,965.199 109.676 2,129.532
202203 1,881.698 111.806 2,000.214
202206 2,181.158 114.083 2,272.258
202209 2,089.037 114.831 2,162.104
202212 2,355.709 115.200 2,430.296
202303 2,306.605 116.550 2,352.086
202306 2,215.417 117.140 2,247.716
202309 2,085.494 119.111 2,080.880
202312 2,318.859 118.848 2,318.859
202403 1,935.986 118.848 1,935.986

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bcworldpharm Co  (XKRX:200780) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bcworldpharm Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5750.00/7543.76
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Bcworldpharm Co was 0.91. The lowest was 0.77. And the median was 0.86.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bcworldpharm Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co (XKRX:200780) Business Description

Industry
Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines